Preferred Label : Osteogenesis imperfecta, type XV;
Symbol : OI15;
CISMeF acronym : OI15;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Oi, type XV;
Description : Osteogenesis imperfecta (OI) is a connective tissue disorder characterized by bone
fragility and low bone mass. Due to considerable phenotypic variability, Sillence
et al. (1979) developed a classification of OI subtypes based on clinical features
and disease severity: OI type I, with blue sclerae (166200); perinatal lethal OI type
II, also known as congenital OI (166210); OI type III, a progressively deforming form
with normal sclerae (259420); and OI type IV, with normal sclerae (166220). Most forms
of OI are autosomal dominant with mutations in one of the 2 genes that code for type
I collagen alpha chains, COL1A1 (120150) and COL1A2 (120160). Keupp et al. (2013)
and Pyott et al. (2013) described osteogenesis imperfecta type XV, an autosomal recessive
form of the disorder characterized by early-onset recurrent fractures, bone deformity,
significant reduction of bone density, short stature, and, in some patients, blue
sclera. Tooth development and hearing are normal. Learning and developmental delays
and brain anomalies have been observed in some patients.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the wingless-type MMTV integration site family, member 1 gene
(WNT1, 164820.0001);
Prefixed ID : #615220;
Origin ID : 615220;
UMLS CUI : C3808844;
CISMeF manual mappings
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)